Table 3.
Relative Associations of Product Characteristics with Side Effects.
| Variables | (1) | (2) | (3) | (4) | (5) | (6) |
|---|---|---|---|---|---|---|
| Negative | % of Negative | Positive | % of Positive | Context-Specific | % of Context-Specific | |
| Concentrate | −0.024 | 0.008 | −0.097** | −0.090** | −0.052 | −0.001 |
| (0.080) | (0.028) | (0.044) | (0.037) | (0.101) | (0.062) | |
| C. indica | 0.079** | 0.015* | 0.011 | −0.033** | 0.030 | 0.045*** |
| (0.035) | (0.009) | (0.017) | (0.016) | (0.026) | (0.010) | |
| C. sativa | 0.003 | −0.002 | −0.000 | −0.022 | −0.041 | −0.043** |
| (0.045) | (0.008) | (0.012) | (0.016) | (0.033) | (0.019) | |
| Pipe | −0.109 | −0.022 | −0.046 | 0.002 | −0.041 | −0.020 |
| (0.077) | (0.024) | (0.060) | (0.021) | (0.045) | (0.035) | |
| Vape | −0.168** | −0.037 | −0.044 | −0.004 | −0.050 | −0.047 |
| (0.076) | (0.024) | (0.049) | (0.024) | (0.059) | (0.031) | |
| THC 10–14% | 0.113*** | 0.013 | 0.017 | 0.055*** | 0.178*** | 0.066*** |
| (0.043) | (0.010) | (0.018) | (0.015) | (0.050) | (0.020) | |
| THC 15–34% | 0.090* | 0.016 | 0.013 | 0.069*** | 0.203*** | 0.085*** |
| (0.053) | (0.013) | (0.019) | (0.018) | (0.051) | (0.021) | |
| THC 35%+ | 0.198** | 0.050** | 0.065* | 0.118*** | 0.182** | 0.095* |
| (0.091) | (0.025) | (0.036) | (0.033) | (0.072) | (0.052) | |
| CBD 1–9% | 0.030 | −0.007 | 0.000 | −0.051*** | −0.007 | −0.009 |
| (0.042) | (0.014) | (0.015) | (0.018) | (0.038) | (0.024) | |
| CBD 10–34% | 0.027 | −0.012 | 0.011 | −0.032* | −0.013 | 0.005 |
| (0.029) | (0.008) | (0.013) | (0.018) | (0.047) | (0.028) | |
| CBD 35%+ | 0.042 | −0.017 | 0.016 | −0.033 | 0.093 | −0.027 |
| (0.062) | (0.022) | (0.024) | (0.022) | (0.070) | (0.053) | |
| Starting Symptom Level | 0.005 | 0.003** | 0.001 | −0.003 | 0.007 | 0.003 |
| (0.007) | (0.001) | (0.002) | (0.002) | (0.005) | (0.002) | |
| Constant | 0.566*** | 0.108*** | 0.988*** | 0.288*** | 0.629*** | 0.160*** |
| (0.081) | (0.023) | (0.048) | (0.029) | (0.077) | (0.039) | |
| Observations | 3,220 | 3,220 | 3,220 | 3,220 | 3,220 | 3,220 |
| R-squared | 0.016 | 0.015 | 0.009 | 0.047 | 0.025 | 0.052 |
| N Users | 665 | 665 | 665 | 665 | 665 | 665 |
Notes: Regressions control for individual user fixed effects. The Concentrate is relative to Flower, C. indica and C. sativa are relative to Hybrid, THC categories are relative to THC between 0 and 10%, and CBD categories are relative to 0% CBD, and Pipe and Vape are relative to Joint. Standard errors are clustered at the user level (shown in parentheses). ***p < 0.01, **p < 0.05, *p < 0.1.